Greenwich Rx Recalls Compounded Sterile Products Over Sterility Assurance Concerns
Greenwich Rx, a US-based compounding pharmacy, has initiated a voluntary nationwide recall for specific lots of compounded sterile products that remain within their beyond-use dates. The recall applies to sterile products dispensed directly by Greenwich Rx as well as preparations compounded for Clove Rx. The action was triggered by potential sterility assurance concerns identified following an inspection by the US FDA.
Using drug products that are intended to be sterile but lack sterility assurance can lead to severe and potentially life-threatening infections. Greenwich Rx stated that no contamination has been detected in the recalled lots and no adverse reactions have been reported to date, but the recall is being conducted as a precautionary measure. The impacted products were dispensed between August 10, 2026, and September 21, 2026.
The pharmacy advises healthcare facilities and patients holding recalled lots to stop using them immediately and discard them safely. Consumers who experience symptoms or problems linked to the use of these preparations should contact their healthcare provider.
Key points
- Greenwich Rx voluntarily recalled specific lots of compounded sterile products within their beyond-use dates due to potential sterility assurance issues.
- The recall includes preparations dispensed directly or compounded for Clove Rx between August 10, 2026, and September 21, 2026.
- No contamination has been confirmed and no adverse events have been reported to date.
- Clinics and patients are instructed to stop using the affected preparations immediately and safely discard them.
What it means for you
This recall underscores the strict adherence to quality and sterility assurance required for all sterile preparations. While these compounded products were distributed in the United States, healthcare professionals in Pakistan should consult the Drug Regulatory Authority of Pakistan (DRAP) regarding the sourcing and registration of any imported sterile medications. Any suspected contamination or related adverse events should be reported to local pharmacovigilance channels.
Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance
Summarised automatically from the official announcement. For educational purposes only — check the original source before making clinical decisions.
